ANEW Medical (KLTO): יחס שווי שוק להכנסות

The flexibility of the Klotho Neurosciences Inc (KLTO) scientific team is ensured by the complete outsourcing of production and testing. The company's current P/S ratio clearly demonstrates the market valuation of the asset, where the current mark equals . Patents for the Klotho protein and investor support establish the fundamental base, however, the lack of revenue at the preclinical stage creates serious risks of a cash crunch.

The P/S ratio determines the market value of a business relative to its revenue, serving as a key tool for assessing revenue generation efficiency. This multiple compares total market capitalization with sales volume to reveal the extent of the asset's overvaluation. By analyzing the price-to-sales multiple history, an investor can track the dynamics of market expectations. For Klotho Neurosciences Inc (KLTO), the growth of this metric is driven by the potential of the Klotho protein in Alzheimer's therapy and the influx of strategic capital.